ADVERTISEMENT

AIG sells Alico unit to MetLife

March 08, 2010 10:36 pm | Updated 10:36 pm IST - NEW YORK:

An AIG office building in New York. Photo: AP

American International Group will sell its overseas life and health insurance unit for $15.5 billion to MetLife Inc., the insurer said on Monday, as it attempted to repay billions in government aid.

In the deal announced on Monday, MetLife will pay $6.8 billion in cash, and the balance in stock and equity units.

The cash portion of the sale will be used to reduce a $47.9 billion investment in AIG by the Federal Reserve Bank of New York.

ADVERTISEMENT

“With this sale of Alico, along with the sale of AIA to Prudential PLC announced last week, we are on track to generate approximately $50.7 billion from these two transactions alone, consisting of about $31.5 billion in cash to repay the FRBNY, plus another about $19.2 billion in securities that we will sell over time to repay the government,” said AIG Chairman Harvey Golub. “Both sales give AIG greater flexibility to move forward with our restructuring and rebuilding efforts.” AIG owes the government almost $130 billion in bailout funds, including $47.3 billion owed to the U.S. Treasury and $34.5 billion in assistance tied to the value of investments the New York Fed bought to prop up AIG. The deal will give MetLife a larger presence in Japan as well as high-growth markets in Europe, the Middle East and Latin America.

Alico, which operates in more than 50 countries, is the second international unit AIG has sold this month. On March 1, AIG said it would sell a cornerstone of its business, Asia-based life insurer AIA Group, to Britain's Prudential PLC in a government—approved $35.5 billion deal.

This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
This is your last free article.

ADVERTISEMENT

ADVERTISEMENT